追缴医保基金4.6亿!去年共关停299家医药机构

2022-01-11 人民日报 网络

截至2021年12月25日,共侦破各类诈骗医保基金犯罪案件1780余起,抓获犯罪嫌疑人4240余名。

2021年,全国公安机关按照统一部署,将依法打击诈骗医保基金犯罪作为“我为群众办实事”实践活动的重要举措,破案件、打团伙、追赃款、建机制,向各类诈骗医保基金犯罪发起凌厉攻势,取得阶段性显著成效。

——截至2021年12月25日,共侦破各类诈骗医保基金犯罪案件1780余起,抓获犯罪嫌疑人4240余名,追缴涉案医保基金4.6亿元,联合医保部门关停处置医药机构299家。

——公安部先后挂牌督办22起重大案件,重点打击“假病人”“假病情”“假票据”等犯罪活动,成功打掉犯罪团伙340余个,成功侦破一批重大影响案件。

——针对犯罪分子通过非法经营医保回收药品牟利等情况,集中侦破349起非法经营医保药品案件,抓获犯罪嫌疑人1270余名,涉案金额达15亿元,有力震慑了此类犯罪活动。

专项整治行动中,各地公安机关勇于担当、主动作为,依法严厉打击幕后组织操纵者、骨干成员,坚决斩断非法利益链条,依法惩处职业收卡人、非法贩卖药品者等相关人员,全面查清犯罪团伙的资金流向,全力追缴赃款赃物,努力实现“打早打小、露头就打”。加强与医保、卫健等部门协作配合,完善监管机制,加强源头防范,最大限度预防和减少此类案件的发生。同时,加强以案释法,强化宣传教育,及时公布一批典型案例,积极拓宽举报渠道,营造全民广泛参与支持的浓厚氛围。

下一步,公安机关将进一步加大对诈骗医保基金犯罪的打击力度,主动进攻、以打开路、以打促防,广辟线索来源,强化全链条打击,既打骗保活动,又打流通环节,确保专项整治行动取得更大成效,坚决守住人民群众“看病钱”“救命钱”,坚决遏制诈骗医保基金违法犯罪高发多发态势。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1221964, encodeId=c3fe122196490, content=<a href='/topic/show?id=e85c33804e5' target=_blank style='color:#2F92EE;'>#医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33804, encryptionId=e85c33804e5, topicName=医保)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:05:33 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719712, encodeId=51c41e1971201, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Fri Feb 18 07:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410191, encodeId=5cf5141019160, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Feb 18 02:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435025, encodeId=026a1435025e1, content=<a href='/topic/show?id=ab323383457' target=_blank style='color:#2F92EE;'>#医保基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33834, encryptionId=ab323383457, topicName=医保基金)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 18 02:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1221964, encodeId=c3fe122196490, content=<a href='/topic/show?id=e85c33804e5' target=_blank style='color:#2F92EE;'>#医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33804, encryptionId=e85c33804e5, topicName=医保)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:05:33 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719712, encodeId=51c41e1971201, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Fri Feb 18 07:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410191, encodeId=5cf5141019160, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Feb 18 02:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435025, encodeId=026a1435025e1, content=<a href='/topic/show?id=ab323383457' target=_blank style='color:#2F92EE;'>#医保基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33834, encryptionId=ab323383457, topicName=医保基金)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 18 02:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1221964, encodeId=c3fe122196490, content=<a href='/topic/show?id=e85c33804e5' target=_blank style='color:#2F92EE;'>#医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33804, encryptionId=e85c33804e5, topicName=医保)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:05:33 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719712, encodeId=51c41e1971201, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Fri Feb 18 07:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410191, encodeId=5cf5141019160, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Feb 18 02:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435025, encodeId=026a1435025e1, content=<a href='/topic/show?id=ab323383457' target=_blank style='color:#2F92EE;'>#医保基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33834, encryptionId=ab323383457, topicName=医保基金)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 18 02:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=)]
    2022-02-18 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1221964, encodeId=c3fe122196490, content=<a href='/topic/show?id=e85c33804e5' target=_blank style='color:#2F92EE;'>#医保#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33804, encryptionId=e85c33804e5, topicName=医保)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:05:33 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719712, encodeId=51c41e1971201, content=<a href='/topic/show?id=a29335349f4' target=_blank style='color:#2F92EE;'>#医药机构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35349, encryptionId=a29335349f4, topicName=医药机构)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=078f32798664, createdName=cenghis, createdTime=Fri Feb 18 07:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410191, encodeId=5cf5141019160, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Feb 18 02:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435025, encodeId=026a1435025e1, content=<a href='/topic/show?id=ab323383457' target=_blank style='color:#2F92EE;'>#医保基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33834, encryptionId=ab323383457, topicName=医保基金)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Feb 18 02:53:26 CST 2022, time=2022-02-18, status=1, ipAttribution=)]

相关资讯

山西忻州13家医疗机构违规使用医保基金被通报处理

7月5日,中国新闻网报道称,山西省忻州市医保局近日通报13起定点医疗机构违规使用医疗保障基金典型案例,涉及

中国太保:用大数据为医保基金平稳运行筑起护城河

医保基金作为百姓的“救命钱”,其收入与支出的变动时刻牵动着人们的心。

首部医保基金监管条例出台,平安医保科技如何演绎“未来时”?

医保基金是老百姓看病就医的“钱袋子”,有人却把它当成“唐僧肉”。2月19日,国务院发布我国首部医保监管条例《医疗保障基金使用监督管理条例》,向医保基金使

南京通报6起欺诈骗保典型案例,全年追回医保基金上千万元

南京医保局近日通报2019年6起欺诈骗保典型案例,其中3起移送至司法机关追究刑事责任。记者从南京市医保局获悉,2019年是医疗保障基金监管年,南京市医疗保障部门组织开展打击欺诈骗保专项治理行动和“百日行动”,坚决守护好老百姓的“救命钱”。 截至11月底,南京全市共现场检查定点医药机构3228家,占全市定点医药机构总量的100%,全市累计处理定点医药机构302家,其中暂停医保服务48家,解

国务院:医保基金收支平衡压力不断增大,更多高值耗材将纳入集采

近日,国家医保局局长胡静林在《学习时报》发布文章《推动医疗保障高质量发展》。其在总结了“十三五”时期医疗保障改革发展取得的成效后,表示要破难点、找支点,以医保“小切

医保基金持续承压,如何做好事前、事中监管?

记者近期梳理国家医保局官网信息发现,相比过去平均一个月一次的调研频率,今年受疫情因素影响,国家医保局领导层赴各地调研次数有所减少,但有关医保基金监管的调研仍未停止。